Cordran Tape
NDC Package 16110-587-80
Package Information
Cordran (flurandrenolide) tapes is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). This formulation utilizes a tape delivery system. Marketed by Almirall, Llc, this product is identified by NDC 16110-587 and is authorized under FDA application NDA016455.
Identification & Billing
- RxCUI: 797694 - flurandrenolide 0.004 MG/SQCM Medicated Tape
- RxCUI: 797697 - Cordran 0.004 MG/SQCM Medicated Tape
- RxCUI: 797697 - flurandrenolide 0.004 MG/SQCM Medicated Tape [Cordran]
- RxCUI: 797697 - Cordran 4 MCG/SQCM Medicated Tape
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16110 - Almirall, Llc
- 16110-587 - Cordran
- 16110-587-80 - 1 BOTTLE in 1 CARTON / 1500 cm2 in 1 BOTTLE
- 16110-587 - Cordran
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (16110-587). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16110-587-80 identifies a specific commercial package of 1 bottle in 1 carton / 1500 cm2 in 1 bottle of Cordran, a human prescription drug labeled by Almirall, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tape is formulated for topical use and contains flurandrenolide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Almirall, Llc on September 24, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Flurandrenolide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid. The tape acts to protect the treated skin and makes the medication more effective and longer-lasting.
How is this Almirall, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16110058780. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.